GeneOne Life Science Inc (011000) — Free Cash Flow Generation Index

Latest as of December 2021: -8.66x

GeneOne Life Science Inc (011000) has a Free Cash Flow Generation Index of -8.66x as of December 2021. Free cash flow of ₩-31.74 Billion represents -9% of operating cash flow (₩3.67 Billion). Explore GeneOne Life Science Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-8.66x
Free Cash Flow / Operating CF

Free Cash Flow

₩-31.74 Billion
KRW

Operating Cash Flow

₩3.67 Billion
KRW

Capital Expenditures

₩35.40 Billion
KRW

GeneOne Life Science Inc Free Cash Flow Generation Index (2015–2015)

Historical FCF Generation Index trend for GeneOne Life Science Inc across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does GeneOne Life Science Inc generate cash.

Annual Free Cash Flow Generation for GeneOne Life Science Inc (2015–2015)

Year-by-year Free Cash Flow Generation Index for GeneOne Life Science Inc. Check how aggressively does GeneOne Life Science Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2015 3.62x ₩2.82 Billion ₩778.50 Million ₩2.04 Billion —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).